The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...

While both broadly agreed with the company’s plans to spin off its consumer-health unit, they questioned whether Chief ...

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

Almost half of councils in England risk falling into bankruptcy without action to address a £4.6bn deficit amassed under a ...

The pharma giant has operated in Ireland for decades and continues to have operations in key locations such as Cork and ...

GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...

Dame Emma Walmsley Thanks Julie. so in summary, GSK is powering forward. This comes on the back of a strong track record of operational delivery and accelerating progress in innovation and ...